2022
DOI: 10.1007/s00277-022-04829-4
|View full text |Cite
|
Sign up to set email alerts
|

Real-world experience of anti-D immunoglobulin in immune thrombocytopenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…Doses (single, i.v.) are in the range of 50-75 µg/kg, and close monitoring is recommended in Rh(D) positive patients to prevent secondary hemolytic anemia [16,17]. Finally, the promising results obtained with vitamin D supplementation in children with persistent and chronic ITP suggest that vitamin D may play an immunomodulatory role in ITP and, therefore, may be a therapeutic target [18].…”
Section: Before/after Splenectomymentioning
confidence: 99%
“…Doses (single, i.v.) are in the range of 50-75 µg/kg, and close monitoring is recommended in Rh(D) positive patients to prevent secondary hemolytic anemia [16,17]. Finally, the promising results obtained with vitamin D supplementation in children with persistent and chronic ITP suggest that vitamin D may play an immunomodulatory role in ITP and, therefore, may be a therapeutic target [18].…”
Section: Before/after Splenectomymentioning
confidence: 99%